|
1
|
Trzpis M, McLaughlin PM, de Leij LM and
Harmsen MC: Epithelial cell adhesion molecule: More than a
carcinoma marker and adhesion molecule. Am J Pathol. 171:386–395.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Linuma H, Okinaga K, Adachi M, Suda K,
Sekine T, Sakagawa K, Baba Y, Tamura J, Kumagai H and Ida A:
Detection of tumor cells in blood using CD45 magnetic cell
separation followed by nested mutant allele-specific amplification
of p53 and K-ras genes in patients with colorectal cancer. Int J
Cancer. 89:337–344. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Balic M, Lin H, Williams A, Datar RH and
Cote RJ: Progress in circulating tumor cell capture and analysis:
Implications for cancer management. Expert Rev Mol Diagn.
12:303–312. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bostick PJ, Chatterjee S, Chi DD, Huynh
KT, Giuliano AE, Cote R and Hoon DS: Limitations of specific
reverse-transcriptase polymerase chain reaction markers in the
detection of metastases in the lymph nodes and blood of breast
cancer patients. J Clin Oncol. 16:2632–2640. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Sang M, Wu X, Fan X, Sang M, Zhou X and
Zhou N: Multiple MAGE-A genes as surveillance marker for the
detection of circulating tumor cells in patients with ovarian
cancer. Biomarkers. 19:34–42. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Joosse SA, Müller V, Steinbach B, Pantel K
and Schwarzenbach H: Circulating cell-free cancer-testis MAGE-A RNA
BORIS RNA, let-7b and miR-202 in the blood of patients with breast
cancer and benign breast diseases. Br J Cancer. 26:909–917. 2014.
View Article : Google Scholar
|
|
7
|
Jheon S, Hyun DS, Lee SC, Yoon GS, Jeon
CH, Park JW, Park CK, Jung MH, Lee KD and Chang HK: Lung cancer
detection by a RT-nested PCR using MAGE A1-6 common primers. Lung
Cancer. 43:29–37. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ries J, Schultze-Mosgau S, Neukam F,
Diebel E and Wiltfang J: Investigation of the expression of
melanoma antigen-encoding genes (MAGE-A1 to -A6) in oral squamous
cell carcinomas to determine potential targets for gene-based
cancer immunotherapy. Int J Oncol. 26:817–824. 2005.PubMed/NCBI
|
|
9
|
Kwon S, Kang SH, Ro J, Jeon CH, Park JW
and Lee ES: The melanoma antigen gene as a surveillance marker for
the detection of circulating tumor cells in patients with breast
carcinoma. Cancer. 104:251–256. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yu N, Zhou J, Cui F and Tang X:
Circulating tumor cells in lung cancer: Detection methods and
clinical applications. Lung. 193:157–171. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wang S, Zheng G, Cheng B, Chen F, Wang Z,
Chen Y, Wang Y and Xiong B: Circulating tumor cells (CTCs) detected
by RT-PCR and its prognostic role in gastric cancer: A
meta-analysis of published literature. PLoS One. 9:e992592014.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yadegarazari R, Hassanzadeh T, Majlesi A,
Keshvari A, Esfahani A Monsef, Tootoonchi A, Shabab N and Saidijam
M: Improved real-time RT-PCR assays of two colorectal cancer
peripheral blood mRNA biomarkers: A pilot study. Iran Biomed J.
17:15–21. 2013.PubMed/NCBI
|
|
13
|
Chebel A, Rouault JP, Urbanowicz I,
Baseggio L, Chien WW, Salles G and Ffrench M: Transcriptional
activation of hTERT, the human telomerase reverse transcriptase, by
nuclear factor of activated T cells. J Biol Chem. 284:35725–35734.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Liu HY, Qian HH, Zhang XF, Li J, Yang X,
Sun B, Ma JY, Chen L and Yin ZF: Improved method increases
sensitivity for circulating hepatocellular carcinoma cells. World J
Gastroenterol. 21:2918–2925. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Edge S, Byrd DR, Compton CC, Fritz AG,
Greene FL and Trotti A: AJCC Cancer Staging Manual. 7th. Springer
Corp.; New York, NY: pp. 117–376. 2010
|
|
16
|
Majima T, Ichikura T, Takayama E, Chochi K
and Mochizuki H: Detecting circulating cancer cells using reverse
transcriptase-polymerase chain reaction for cytokeratin mRNA in
peripheral blood from patients with gastric cancer. Jpn J Clin
Oncol. 30:499–503. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Uen YH, Lin SR, Wu CH, Hsieh JS, Lu CY, Yu
FJ, Huang TJ and Wang JY: Clinical significance of MUC1 and c-Met
RT-PCR detection of circulating tumor cells in patients with
gastric carcinoma. Clin Chim Acta. 367:55–61. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ortega FG, Lorente JA, Puche JL Garcia,
Ruiz MP, Sanchez-Martin RM, de Miguel-Pérez D, Diaz-Mochon JJ and
Serrano MJ: miRNA in situ hybridization in circulating tumor
cells-MishCTC. Sci Rep. 5:92072015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Pearl ML, Dong H, Tulley S, Zhao Q,
Golightly M, Zucker S and Chen WT: Treatment monitoring of patients
with epithelial ovarian cancer using invasive circulating tumor
cells (iCTCs). Gynecol Oncol. 2:229–238. 2015. View Article : Google Scholar
|
|
20
|
Wang HY, Ahn S, Kim S, Park S, Jung D,
Park S, Han H, Sohn J, Kim S and Lee H: Detection of circulating
tumor cell-specific markers in breast cancer patients using the
quantitative RT-PCR assay. Int J Clin Oncol. 20:878–890. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Strati A, Kasimir-Bauer S, Markou A,
Parisi C and Lianidou ES: Comparison of three molecular assays for
the detection and molecular characterization of circulating tumor
cells in breast cancer. Breast Cancer Res. 15:R202013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kim JH, Jin HO, Park JA, Chang YH, Hong YJ
and Lee JK: Comparison of three different kits for extraction of
high-quality RNA from frozen blood. Springerplus. 3:762014.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Jiang Z, Uboh CE, Chen J and Soma LR:
Isolation of RNA from equine peripheral blood cells: Comparison of
methods. Springerplus. 2:4782013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Man Y, Cao J, Jin S, Xu G, Pan B, Shang L,
Che D, Yu Q and Yu Y: Newly identified biomarkers for detecting
circulating tumor cells in lung adenocarcinoma. Tohoku J Exp Med.
234:29–40. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Shen C, Hu L, Xia L and Li Y: The
detection of circulating tumor cells of breast cancer patients by
using multimarker (Survivin, hTERT and hMAM) quantitative real-time
PCR. Clin Biochem. 42:194–200. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yu Y, Xu G, Cao J, Jin S, Man Y and Shang
L: Combination of four gene markers to detect circulating tumor
cells in the peripheral blood of patients with advanced lung
adenocarcinoma using real-time PCR. Oncol Lett. 5:1400–1406.
2013.PubMed/NCBI
|
|
27
|
Kolostova K, Matkowski R, Gürlich R,
Grabowski K, Soter K, Lischke R, Schützner J and Bobek V: Detection
and cultivation of circulating tumor cells in gastric cancer.
Cytotechnology. 68:1095–1102. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Iinuma H, Watanabe T, Mimori K, Adachi M,
Hayashi N, Tamura J, Matsuda K, Fukushima R, Okinaga K, Sasako M
and Mori M: Clinical significance of circulating tumor cells,
including cancer stem-like cells, in peripheral blood of recurrence
and prognosis in patients with Dukes' stage B and C colorectal
cancer. J Clin Oncol. 29:1547–1555. 2011. View Article : Google Scholar : PubMed/NCBI
|
